Pioneering Physician-Scientist Dr. Francis S. Collins Joins ImmunoBrain Board of Directors
ImmunoBrain, a clinical-stage biopharmaceutical company developing novel immunotherapies for neurodegenerative diseases, today announced the appointment of Francis S. Collins, MD, PhD, to its board of directors. https://mma.prnewswire.com/media/2770434/ImmunoBrain_Logo.jpg Dr. Collins, a pioneering physician-scientist, served as the 16th director of the National Institutes of Health under three United States presidents. In this role, he guided the nation's […]